Recent KA News
- Form 8-K - Current report • Edgar (US Regulatory) • 05/30/2024 08:00:12 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/15/2024 08:03:12 PM
- Kineta Reports First Quarter 2024 Financial Results and Provides Update on its Ongoing Phase 1/2 VISTA-101 Clinical Trial and Corporate Activities • GlobeNewswire Inc. • 05/15/2024 08:01:00 PM
- Kineta Reports Initial Clinical Response Data at AACR 2024 of its Ongoing Phase 1/2 VISTA-101 Clinical Trial • GlobeNewswire Inc. • 04/08/2024 08:01:00 PM
- Kineta Reports Full Year 2023 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 03/21/2024 08:02:00 PM
- KVA12123 Clears Additional Cohorts in Monotherapy and in Combination Therapy Arms in the Phase 1/2 VISTA-101 Clinical Trial; Initial Clinical Response Data Reported • GlobeNewswire Inc. • 03/12/2024 12:00:00 PM
- Kineta Announces Restructuring and Exploration of Strategic Alternatives • GlobeNewswire Inc. • 02/29/2024 01:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/29/2024 12:00:14 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 02/14/2024 08:40:31 PM
- Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 02/12/2024 09:05:45 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/12/2024 09:05:16 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/17/2024 01:30:09 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/05/2024 09:30:28 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/15/2023 01:30:30 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/06/2023 11:21:27 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/30/2023 10:21:22 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 11/13/2023 10:28:31 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/06/2023 01:30:22 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 11/03/2023 08:25:46 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/03/2023 08:04:48 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/03/2023 08:02:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/03/2023 08:01:09 PM
- Form D - Notice of Exempt Offering of Securities • Edgar (US Regulatory) • 10/20/2023 05:04:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/17/2023 12:32:54 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/12/2023 08:25:50 PM
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM
ECGI Holdings Targets $9.7 Billion Equestrian Apparel Market with Allon Brand Launch • ECGI • Jun 25, 2024 8:36 AM
Avant Technologies Addresses Progress on AI Supercomputer-Driven Data Centers • AVAI • Jun 25, 2024 8:00 AM
Green Leaf Innovations, Inc. Expands International Presence with New Partnership in Dubai • GRLF • Jun 24, 2024 8:30 AM
Bemax Inc. Positions to Capitalize on Industry Growth with New Improved Quality of Mother's Touch® Disposable Diapers • BMXC • Jun 24, 2024 8:00 AM
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM